Translation is the easy part. Claims that differ by market are not.
Medical device sites in multiple languages carry certification, intended purpose and instructions for use that legitimately differ per market — and a mistranslated claim is a regulatory problem, not a copy error.
Sites are routinely built as though choosing a language chooses a market, which fails immediately in this sector: German serves Germany, Austria and Switzerland with different regulatory positions, and a device certified in one may not be available in another. Modelling language and market as separate attributes — so a visitor gets their language with their market’s certification status, availability and documentation — is a foundational decision. Retrofitting it once the site is live means rebuilding the content model, which is why it is worth settling before anything is translated.
What may be said about a device is fixed by the intended purpose in its technical documentation, and that documentation exists per certification. A translator working from marketing copy will produce fluent text that quietly asserts an indication the device is not certified for in that market. The control is structural: claims held as approved statements per market with their translations, reused rather than retranslated, so a linguist never has the opportunity to reinterpret a regulated sentence. Free translation of claim text is the single most common compliance failure in multilingual device sites.
Regulation in the European Union requires instructions for use in the official languages of the member states where a device is placed on the market, and electronic instructions carry specific conditions of their own. This is not a marketing translation exercise: the documents are controlled, versioned and tied to certification, and the website is frequently how a clinician reaches them. Connecting the site to the controlled document source, so the correct language and current version are served for each market, is more consequential than any amount of translated marketing content.
Search engines need to be told which page serves which language and region, and errors here are quietly expensive: the wrong market’s page ranking, or several language versions competing as duplicates. In this sector there is a further consequence, because the wrong page ranking means a clinician reading claims and availability that do not apply where they practise. Getting the language and region signals right is therefore both a visibility and a compliance measure, and it needs to be derived from the same market model the content uses rather than configured separately.
Translated content usually requires review by someone in the local organisation with regulatory competence, and that person has other work. A plan assuming every page exists in twelve languages will produce a site where four languages are current and eight are eighteen months out of date, which is worse than a smaller, accurate site. Deciding deliberately which markets get the full site, which get a reduced core, and how a page is marked as awaiting review, keeps the whole thing honest as it grows.
When a claim changes, a certification lapses or a document is superseded, every language and market version must follow. Where translations are separate copies, this becomes a manual search that is never quite complete, and an obsolete claim survives in a language nobody in head office reads. Holding the source content once with translations attached to it, so a change flags every affected version, is what makes an update a controlled operation rather than an act of faith — and it is what an auditor will ask about.
What comes up when taking a device site into multiple languages and markets.
They need local regulatory sign-off, not just linguistic review. A claim is bounded by the intended purpose in the technical documentation for that market’s certification, and a fluent translation can easily assert something outside it. The practical control is holding approved claim statements per market with their approved translations and reusing them, so translators handle surrounding content while regulated sentences are never reinterpreted in the process.
You need them in the official languages of the member states where the device is placed on the market, and where you provide them electronically there are specific conditions to meet. In practice the website is often how a clinician actually reaches them, so it is worth treating this as a core function rather than a document library afterthought — served from the controlled source, correct version, correct language for the market, rather than as files uploaded manually.
One platform with market and language as configuration, in almost every case. Separate sites multiply maintenance, security patching and content duplication, and they drift — a superseded claim surviving in one country site is a common and serious finding. A single platform gives the same local accuracy while leaving one place to make a change and one place to demonstrate control, which matters when an auditor asks how you keep markets consistent.
By holding availability and certification status as per-market attributes of the product and rendering accordingly, rather than by writing it into page copy. A visitor in a market where the device is not available should not see it presented as though it were, and a status change should be one field to update rather than a search across every page mentioning the product. Doing this in the content model is what keeps it correct as the portfolio and the certifications change.
Claims translated by a linguist who never saw the technical file, instructions for use in a language that is two versions behind, and the wrong market's page ranking. Tell us which markets you serve and we will tell you what we would check first.